Log Out

Bionano Genomics (NASDAQ:BNGO) Shares Gap Down to $1.86

Financial News Live · Sep 26, 2022 11:32

Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) shares gapped down prior to trading on Monday . The stock had previously closed at $1.86, but opened at $1.77. Bionano Genomics shares last traded at $1.88, with a volume of 41,758 shares traded.

Analyst Upgrades and Downgrades

Separately, Oppenheimer reaffirmed an "outperform" rating and set a $12.00 target price on shares of Bionano Genomics in a research note on Monday, July 18th.

Get Bionano Genomics alerts:

Bionano Genomics Price Performance

The business's 50 day simple moving average is $2.37 and its 200-day simple moving average is $1.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.75.

Bionano Genomics (NASDAQ:BNGO – Get Rating) last released its quarterly earnings data on Thursday, August 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). Bionano Genomics had a negative net margin of 453.68% and a negative return on equity of 33.21%. The firm had revenue of $6.67 million for the quarter, compared to analyst estimates of $6.20 million. Equities analysts forecast that Bionano Genomics, Inc. will post -0.44 EPS for the current fiscal year.

Insider Activity at Bionano Genomics

In related news, Director Yvonne Linney sold 20,000 shares of Bionano Genomics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $3.62, for a total value of $72,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Blackston Financial Advisory Group LLC bought a new stake in Bionano Genomics in the 4th quarter valued at $30,000. Merit Financial Group LLC bought a new position in Bionano Genomics during the first quarter worth about $28,000. Freestone Capital Holdings LLC acquired a new stake in Bionano Genomics during the first quarter valued at approximately $29,000. Magnus Financial Group LLC bought a new stake in shares of Bionano Genomics in the 1st quarter valued at approximately $33,000. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Bionano Genomics in the 1st quarter worth approximately $33,000. 28.44% of the stock is owned by institutional investors.

Bionano Genomics Company Profile

(Get Rating)

Bionano Genomics, Inc provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.